24 An increasing trend of anemia with an increasing boce-previr AUC has been reported. 25 Boceprevir is primarily metabolized by the aldoketoreductase-mediated pathway to inactive ketone metabolites.
1
—
—
24 An increasing trend of anemia with an increasing boce-previr AUC has been reported. 25 Boceprevir is primarily metabolized by the aldoketoreductase-mediated pathway to inactive ketone metabolites.